Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R McKay

Showing results (871-880 of 932) with videos related to

Pageof 94
Sort By:
Cancer Immunology Research|May 12, 2018
The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell CarcinomaRana R McKay, Dominick Bossé, Wanling Xie, et al.
European Urology Oncology|July 19, 2025
Radiotherapy- Versus Surgery-based Treatment Strategy in High-risk Prostate CancerSoumyajit Roy, Yilun Sun, James A Eastham, et al.
The Oncologist|June 19, 2025
REFINE: a database of linked clinical data and genomic biomarkers in renal cell carcinoma patients receiving immunotherapy-based treatment regimensJeffrey Zhong, Albert Jang, Bashar Abuqayas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2016
Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological CorrelationsLaurence Albiges, A Ari Hakimi, Wanling Xie, et al.
JCO Precision Oncology|April 5, 2024
Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable AlterationsJoseph J Park, Alec Chu, Jinju Li, et al.
Nature Communications|December 16, 2025
Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancerSoumyajit Roy, Yilun Sun, Maha Hussain, et al.
European Urology|January 24, 2025
A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer TypesAxel Bex, Michael Jewett, Bryan Lewis, et al.
Clinical Genitourinary Cancer|January 11, 2025
Clinical Outcomes With Immune Checkpoint Inhibitors in Patients With FGFR2/3, MTAP or ERBB2 Genomic Alterations in Advanced Urothelial CarcinomaRafee Talukder, Dimitra Rafailia Bakaloudi, Dimitrios Makrakis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 27, 2021
COVID-19 vaccination and breakthrough infections in patients with cancerA L Schmidt, C Labaki, C-Y Hsu, et al.
JACC. Cardiooncology|March 21, 2024
Clinical Outcomes Among Immunotherapy-Treated Patients With Primary Cardiac Soft Tissue Sarcomas: A Multicenter Retrospective StudyAmin H Nassar, Edward El-Am, Ryan Denu, et al.
Pageof 94

Showing results (871-880 of 932) with videos related to

Sort By:
Pageof 94
Cancer Immunology Research|May 12, 2018
The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell CarcinomaRana R McKay, Dominick Bossé, Wanling Xie, et al.
European Urology Oncology|July 19, 2025
Radiotherapy- Versus Surgery-based Treatment Strategy in High-risk Prostate CancerSoumyajit Roy, Yilun Sun, James A Eastham, et al.
The Oncologist|June 19, 2025
REFINE: a database of linked clinical data and genomic biomarkers in renal cell carcinoma patients receiving immunotherapy-based treatment regimensJeffrey Zhong, Albert Jang, Bashar Abuqayas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2016
Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological CorrelationsLaurence Albiges, A Ari Hakimi, Wanling Xie, et al.
JCO Precision Oncology|April 5, 2024
Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable AlterationsJoseph J Park, Alec Chu, Jinju Li, et al.
Nature Communications|December 16, 2025
Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancerSoumyajit Roy, Yilun Sun, Maha Hussain, et al.
European Urology|January 24, 2025
A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer TypesAxel Bex, Michael Jewett, Bryan Lewis, et al.
Clinical Genitourinary Cancer|January 11, 2025
Clinical Outcomes With Immune Checkpoint Inhibitors in Patients With FGFR2/3, MTAP or ERBB2 Genomic Alterations in Advanced Urothelial CarcinomaRafee Talukder, Dimitra Rafailia Bakaloudi, Dimitrios Makrakis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 27, 2021
COVID-19 vaccination and breakthrough infections in patients with cancerA L Schmidt, C Labaki, C-Y Hsu, et al.
JACC. Cardiooncology|March 21, 2024
Clinical Outcomes Among Immunotherapy-Treated Patients With Primary Cardiac Soft Tissue Sarcomas: A Multicenter Retrospective StudyAmin H Nassar, Edward El-Am, Ryan Denu, et al.
Pageof 94